Drugs A - Z

metoclopramide Images

Generic Name: metoclopramide

Brand Names: Metozolv ODT, Reglan, Metoclopramide Hydrochloride

There is an FDA Alert for this drug. Click here to view it.

    Tardive Dyskinesia
  • May result in tardive dyskinesia. Risk increases with increasing duration of therapy and total cumulative dose. (See Tardive Dyskinesia under Cautions.)
  • Discontinue metoclopramide in patients who develop signs or symptoms of tardive dyskinesia. There is no known treatment for tardive dyskinesia; however, symptoms may lessen or resolve in some patients after discontinuance.
  • Avoid use for >12 weeks in all but rare cases where therapeutic benefit is thought to outweigh risk of developing tardive dyskinesia.

REMS:

FDA approved a REMS for metoclopramide to ensure that the benefits of a drug outweigh the risks. The REMS may apply to one or more preparations of metoclopramide and consists of the following: medication guide. See the FDA REMS page ([Web]) or the ASHP REMS Resource Center ([Web]).

The Healthline Site, its content, such as text, graphics, images, search results, HealthMaps, Trust Marks, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.
Advertisement